Table 2.
Overview of mental health and opioid use disorder learning collaborative sessions, content, and attendance.
| Topic | Didactic content | Wave 1 | Wave 2 | Community X | |||
|---|---|---|---|---|---|---|---|
| Case example included (yes/no) | Total attendance/non-HCS attendancea (# of feedback responses) | Case example included (Yes/No) | Total attendance/non-HCS attendancea (# of feedback responses) | Case example included (yes/no) | Total attendance/non-HCS attendancea (# of feedback responses) | ||
| Posttraumatic stress disorder (PTSD) | A presentation on the intersection of PTSD and OUD. | Yes | 32/16 (4) | No | 22/12 (NR) | Yes | 35/24 (9) |
| Bipolar disorder | A presentation on the diagnosis and management of bipolar and OUD. | Yes | 22/13 (7) | No | 17/12 (3) | Nob | 64/49 (13) |
| Sleep | A presentation on the intersection of sleep and OUD. | Yes | 20/12 (4) | No | 21/13 (5) | NA | NA |
| Motivational interviewing (MI) | A presentation on specific MI tools for effective conversations about change. | Yes | 41/31 (6) | No | 26/21 (8) | NA | NA |
| Suicide | Presentation(s) on suicide prevention and OUD. Wave 1 had a two-part series, and wave 2 had a single presentation. | Nob | Part 1: 37/29 (4) Part 2: 24/18 (3) | No | 36/26 (NR) | NA | NA |
| Alcohol use disorder (AUD) | A presentation on the intersection of AUD and OUD. | Yes | 52/43 (11) | No | 32/21 (8) | NA | NA |
| Medications for AUD | A presentation on medications for AUD in people with OUD. | NA | NA | No | 19/15 (2) | NA | NA |
| De-escalation | A presentation on de-escalation techniques for people with OUD. | Yes | 51/42 (11) | No | 59/50 (1) | NA | NA |
| Anxiety disorders | A presentation on the intersection of anxiety and OUD. | No | 37/30 (13) | No | 28/15 (NR) | NA | NA |
| Trauma-informed care (TIC) | A presentation on providing trauma-informed care for patients with OUD. | Yes | 33/27 (2) | NA | NA | No | 25/14 (1) |
| Civil commitment | A presentation on section 12 & 35 civil commitment criteria. | No | 40/30 (7) | No | 23/12 (3) | NA | NA |
| Treatments for stimulant use disorders | A presentation on stimulant use, withdrawal, and behavioral management. | No | 34/28 (6) | Yes | 24/19 (6) | NA | NA |
| Personality disorders | A presentation on the intersection of personality disorders and OUD. | NA | NA | No | 27/29 (NR) | Yes | 51/40 (6) |
| ADHD | A presentation on the intersection of ADHD and OUD. | NA | NA | No | 22/12 (2) | NA | NA |
| Depression | A presentation on the intersection of depression and OUD. | NA | NA | No | 14/8 (2) | Yes | 34/24 (3) |
| Benzodiazepines | A presentation on the topic of prescribing benzodiazepines for patients with SUD. | NA | NA | NA | NA | No | 28/17 (2) |
| Final session roundtable topics | A series of roundtable, high-level summary presentation on key mental health and OUD topics previously covered. | NA | NA | No | 19/7 (NR) | NA | NA |
aTotal Attendance includes all HCS staff, host(s), presenter(s), and facilitator(s).
bThese two sessions were defined as “trainings” instead of LCs because they focused less on participant engagement, including discussion and case presentations, than LCs. Nevertheless, they were part of the LC series and are therefore included in this description.
NA, not applicable indicates a certain topic was not delivered to a given wave; NR, no responses were provided to feedback surveys.